Page 81 - IJPS-9-1
P. 81

International Journal of
            Population Studies                                             COVID-19, economic crisis, insomnia, and stress




            Table 3. Exposure to COVID‑19, health characteristics, PTSS, and insomnia
             Factor                   Frequency (%)       PTSS          p‑value*       Insomnia       p‑value*
                                      N=502 (100%)      Mean (SD)                     mean (SD)
            Contact with COVID-19                                        0.035                         0.439
             Yes (work, family, store)  18 (3.5%)      11.27 (11.75)                  42.58 (11.29)
             No                        484 (96.5%)     17.87 (17.12)                  44.69 (11.24)
            Knows someone infected                                       0.004                         0.339
             Yes                       145 (28.8%)     14.47 (15.01)                  43.86 (11.02)
             No                        357 (71.2%)     18.92 (17.60)                  44.92 (11.33)
            Physical activity                                            0.057                         0.001
             Yes                       321 (64.0%)     16.55 (17.11)                  43.32 (11.41)
             No                        181 (36.0%)     19.57 (16.66)                  46.91 (10.57)
            Having a chronic disease                                     0.524                         0.057
             Yes                       103 (20.5%)     16.69 (16.02)                  46.49 (12.24)
             No                        399 (79.5%)     17.89 (17.25)                  44.13 (10.93)
            Receiving regular treatment                                  0.755                         0.044
             Yes                       127 (25.4%)     17.54 (16.67)                  46.76 (11.62)     Ref
             No                        40 (8.0%)       15.78 (16.20)                  44.05 (10.49)    0.545
             Does not apply            334 (66.6%)     17.91 (17.25)                  43.86 (11.10)    0.040
            Fear no access to treatment                                  0.062                         <0.001
             No                        153 (30.5%)     19.78 (15.01)                  48.94 (10.87)     Ref
             Yes                       136 (27.0%)     15.16 (16.73)                  42.59 (10.51)    <0.001
             Does not apply            213 (42.4%)     18.06 (18.20)                  43.31 (11.29)    <0.001
            Fear to go out get treatment                                 0.119                         0.074
             No                        217 (43.2%)     15.36 (15.02)                  44.60 (11.53)
             Yes                       77 (15.4%)      20.06 (17.82)                  47.11 (10.78)
             Does not apply            208 (41.4%)     19.11 (18.37)                  43.69 (11.01)
            Worried for family member                                    0.002                         0.442
             No                        96 (19.1%)      12.72 (14.06)     Ref          45.81 (11.24)
             Yes                       268 (53.4%)     19.96 (18.14)     0.001        44.12 (11.29)
             Does not apply            138 (27.4%)     16.55 (15.78)     0.037        44.74 (11.14)
                                       Mean (SD)       Unadjusted      p‑value**      Unadjusted      p‑value**
                                                       correlation (r)               correlation (r)
            Fear of COVID-19           11.35 (6.03)       0.424         <0.001          0.229          <0.001
            Note: *Yes versus no modalities comparison. APGAR: Adaptation, Partnership, Growth, Affection, and Resolve; PTSS: Post-traumatic stress symptoms.
            *p-values were based on ANOVA test (and post hoc with Bonferroni adjustment). **p-values were based on Spearman’s correlation test.
            4. Discussion                                      Sun et al., 2020). Such a disparity could be related to the
                                                               cumulation of stressful events experienced by the Lebanese
            This study was carried out 3 months after the first case of   population, including the current pandemic, past and
            COVID-19 was confirmed in Lebanon and 2 months after   prevailing local and regional wars, political instability, and
            the national sanitary lockdown was  declared. It revealed
            relatively high prevalence of PTSS (21.7%) as evaluated by   the economic crisis. Interestingly, the PTSS prevalence
            the PCL-5 scores and moderate prevalence of insomnia   found in this study was similar to the one reported in
            (11.5%) among a sample of the general Lebanese population.   Lebanon (21.6%) immediately after “The Grapes of Wrath”
            The prevalence of insomnia in this study was higher than   war (South Lebanon, 1996). Therefore, in major life-
            that reported in other populations (Rossi et al., 2020; Zhou   threatening disease outbreaks occurring in societies already
            et al., 2021) but lower than what was previously published   struggling  with  economic  difficulties,  understanding  the
            in Lebanon (using the LIS-18 score: 17.9%) (Hallit et al.,   interplay of factors on mental health is crucial to design
            2019) and in other countries (Huang & Zhao, 2020; Kokou-  detection and intervention strategies.
            Kpolou  et al., 2020; Voitsidis  et al., 2020). Discrepancies   4.1. COVID-19, PTSS, and insomnia
            may be due to the use of different assessment tools and
            differences in demographic profiles of populations. Notably,   Our  results  showed  that  FOC  was  the  main factor
            the prevalence of PTSS was higher than that reported in   impacting both PTSS and insomnia. Even if several studies
            China during the pandemic (4.6 and 7%) (Liu et al., 2020;   have assessed PTSS (Liu  et al., 2020; Rossi  et al., 2020)


            Volume 9 Issue 1 (2023)                         75                         https://doi.org/10.36922/ijps.440
   76   77   78   79   80   81   82   83   84   85   86